Log in to nanotech.net

View presentations from the past events and manage your subscription to
Nanotech Europe newsletter

Nanotech Europe 2009 Speakers Included

Dieter Bimberg Professor Dieter Bimberg,
Chairman, Conference Committee & AGeNT-D (Germany)
Peter Andreas Grünberg Peter Andreas Grünberg,
Professor, Nobel Prize Winner 2007, Institute of Solid State Research (Germany)
Emmanuel Desurvire Emmanuel Desurvire,
Director, Thales Research & Technology (France)
Stefan Kienzle Stefan Kienzle,
Director for Materials, Manufacturing and Lightweight, Daimler AG (Germany)
Christos Tokamanis Christos Tokamanis,
Head of Unit "Nano and converging Sciences and Technologies", DG Research, European Commission
Dieter Weller

Dieter Weller,
Manager Future Magnetic Recording Media, Hitachi GST (USA)
Alexander von Preysing Alexander von Preysing,
Senior Vice President, Deutsche Börse AG (Germany)
Jani Kivioja Jani Kivioja,
Research Leader, Nokia Research Center (UK)
View all speakers >>


PARTNERS AND SPEAKERS 2009
Federal Ministry of Education and Research AGeNT-D
Nokia Technology Academy Foundation
The Millennium Technology Prize Chinano
Carl Zeiss Shell International Exploration and Production
Daimler BASF - The Chemical Company
Bayer Material Science Lux Research
Saudi Aramco Bax & Willems Consulting Venturing
Thermo Fisher Scientific Nanotechnologie
Hessen-Nanotech NMN
ENNaB INM
CC NanoChem Upob
INCH CeNTech GmbH
NanOP NanoBioNet
NanoMat
GOLD MEDIA PARTNER 2009
MATCHMAKING PARTNER 2009
Technology Review Enterprise Europe Network
2009 GLOBAL PARTNER
2009 OFFICIAL AIRLINE
nano tech 2010 Lufthansa – German Airlines
2009 CO-ORGANISER
LEAD ORGANISER
TU Berlin Spinverse Consulting


Andreas Jordan Andreas Jordan
Chief Scientific Officer, MagForce Nanotechnologies AG
Germany

Dr. Andreas Jordan, born 1959, founded MagForce Nanotechnologies AG and serves on its management board as chief scientific officer, with responsibility for all research and development activities. He began his career with studies in biology at the Free University of Berlin, followed by further studies in biochemistry at the Technical University of Berlin. His highly praised doctoral dissertation in 1993 addressed the production of nanoparticles and their application for cancer therapy. This pioneering work was based on research which began in 1987, long before the subject of nanotechnology had achieved any international significance. He subsequently managed scientific projects for the Berlin’s Virchow Clinic (now Charité) as well as for the Institute for Diagnostic Research, a subsidiary of Schering.

Dr. Jordan has already delivered more than 500 scientific lectures about Nano-Cancer® therapy. He has authored more than 45 articles for peer-reviewed scientific journals and has cleared the way for twelve families of international patents, some of which have been licensed. His contacts to NASA, the National Cancer Institute (NCI), the Institute of Nanotechnology (IoN), the U.S. Food and Drug Administration (FDA), and such renowned U.S. hospitals as the University of California, San Francisco (UCSF), the Cleveland Clinic Foundation (CCF) and Duke University, as well as throughout Asia, continue to provide an essential foundation for his professional activities through the world.